What We're Reading: Page 89
Industry reads hand-picked by our editors
Feb 09, 2023
-
The Wall Street Journal
Pfizer, Novartis, Merck Executives Say They Are Hunting for Deals Again
-
The New Yorker
The Promise of a New Alzheimer’s Drug
-
Reuters
Why Europe’s drug shortages may get worse
-
Science News
Disorder or difference? Autism researchers face off over field’s terminology
Feb 08, 2023
-
Bloomberg
Nestlé’s $6,000 Peanut Allergy Pill Has Been a Dud
-
Disorder or difference? Autism researchers face off over field’s terminology
-
Scientific American
COVID Rebound Can Happen Even without Paxlovid
-
Healthcare Dive
CVS buys Oak Street Health for $10.6B
Feb 07, 2023
-
The New York Times
‘Miracle’ Cystic Fibrosis Drug Kept Out of Reach in Developing Countries
-
Axios
Biden to push for expanded insulin caps, Medicaid coverage in SOTU
-
Nature
What the WHO’s new treaty could mean for the next pandemic
-
The Wall Street Journal
CVS Nearing $10.5 Billion Deal for Primary-Care Provider Oak Street Health
Feb 06, 2023
Feb 03, 2023
Feb 02, 2023
Feb 01, 2023
-
The New York Times
Vaccine Makers Kept $1.4 Billion in Prepayments for Canceled Covid Shots for the World’s Poor
-
CNBC
Google’s ex-CEO Eric Schmidt tapped for federal biotech commission that allows members to keep biotech investments
-
STAT
6 things to know about Apellis’ eye drug ahead of FDA decision
-
Evaluate Vantage
Novo still cannot meet Wegovy demand
Previous
